The mortality rate of prostate cancer is discordant with its high incidence rate in part due to the substantial number of prostate cancers detected by population-based prostate-specific antigen (PSA) screening, and in part due to the high prevalence of indolent, slow growing cancers [120]. The gene discussed is KLK3; the disease is prostate carcinoma.